Chronic Obstructive Pulmonary Disease Prediction Using Deep Convolutional Network

Abstract

AI and deep learning are two recent innovations that have made a big difference in helping to solve problems in the clinical space. Using clinical imaging and sound examination, they also work on improving their vision so that they can spot diseases early and correctly. Because there aren’t enough trained HR, clinical professionals are asking for help with innovation because it helps them adapt to more patients. Aside from serious health problems like cancer and diabetes, the effects of respiratory infections are also slowly getting worse and becoming dangerous for society. Respiratory diseases need to be found early and treated quickly, so listening to the sounds of the lungs is proving to be a very helpful tool along with chest X-rays. The presented research hopes to use deep learning ideas based on Convolutional Brain Organization to help clinical specialists by giving a detailed and thorough analysis of clinical respiratory sound data for Ongoing Obstructive Pneumonic identification. We used MFCC, Mel-Spectrogram, Chroma, Chroma (Steady Q), and Chroma CENS from the Librosa AI library in the tests we ran. The new system could also figure out how serious the infection was, whether it was mild, moderate, or severe. The test results agree with the outcome of the deep learning approach that was proposed. The accuracy of the framework arrangement has been raised to a score of 96% on the ICBHI. Also, in the led tests, we used K-Crisp Cross-Approval with ten parts to make the presentation of the new deep learning approach easier to understand. With a 96 percent accuracy rate, the suggested network is better than the rest. If you don’t use cross-validation, the model is 90% accurate.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

N/A

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Comments (0)

No login
gif